FIGURE 2.
Mechanism of action of poly (ADP‐ribose) polymerase (PARP) inhibitors in homologous recombination (HR) deficient (mutant BRCA) and HR intact (wildtype BRCA) patients
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.